These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2683937)

  • 21. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
    Berson FG; Cohen HB; Foerster RJ; Lass JH; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):379-82. PubMed ID: 3883972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W; Kimmich F; Walt JG; Lue J
    Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure.
    Duzman E; Ober M; Scharrer A; Leopold IH
    Am J Ophthalmol; 1982 Sep; 94(3):318-27. PubMed ID: 6751091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levobunolol. A three-month efficacy study in the treatment of glaucoma and ocular hypertension.
    Bensinger RE; Keates EU; Gofman JD; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):375-8. PubMed ID: 3883971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glaucoma treatment with once-daily levobunolol.
    Wandel T; Charap AD; Lewis RA; Partamian L; Cobb S; Lue JC; Novack GD; Gaster R; Smith J; Duzman E
    Am J Ophthalmol; 1986 Mar; 101(3):298-304. PubMed ID: 3513594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
    Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
    Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical verapamil and episcleral venous pressure.
    Abreu MM; Kim YY; Shin DH; Netland PA
    Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levobunolol compared with timolol: a four-year study.
    Geyer O; Lazar M; Novack GD; Shen D; Eto CY
    Br J Ophthalmol; 1988 Dec; 72(12):892-6. PubMed ID: 3067745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study.
    Derick RJ; Robin AL; Tielsch J; Wexler JL; Kelley EP; Stoecker JF; Novack GD; Coleman AL
    Ophthalmology; 1992 Mar; 99(3):424-9. PubMed ID: 1565455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimum concentration of levobunolol required to control intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.
    Long D; Zimmerman T; Spaeth G; Novack G; Burke PJ; Duzman E
    Am J Ophthalmol; 1985 Jan; 99(1):18-22. PubMed ID: 3881033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.
    Long DA; Johns GE; Mullen RS; Bowe RG; Alexander D; Epstein DL; Weiss MJ; Masi RJ; Charap AD; Eto CY
    Ophthalmology; 1988 Jun; 95(6):735-41. PubMed ID: 3062529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levobunolol levels following topical administration with reference to systemic side effects.
    Novack GD; Tang-Liu DD; Kelley EP; Liu SS; Shen CD; Duzman E
    Ophthalmologica; 1987; 194(4):194-200. PubMed ID: 3306546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.